Archive: cancer detection
By Early Investing on September 19, 2022
20/20 GeneSystems has been busy. We first recommended the company in December 2017 when we learned about its incredible cancer detection technology. 20/20 GeneSystems identifies cancer risk early on by using tumor antigen markers. It can improve cancer detection by up to 30% through its proprietary machine learning algorithm. In 2020, the company pivoted to COVID testing. At its peak, 20/20 GeneSystems provided 1,200 to 1,300 tests a day. The numbers…
By Andy Gordon on February 4, 2021
Yesterday I wrote about how the medtech and healthcare sector is seeing amazing growth. It’s one of my favorite sectors to look for promising startups in. But my love of this sector is nothing new. And today I want to give you an…
By Adam Sharp on February 10, 2020
A smart biotechnology startup is building a new type of cancer screening and analysis tool.
By Andy Gordon on November 27, 2019
It’s almost Thanksgiving, so here are five future disruptive technologies that Andy Gordon is already thankful for.
By Andy Gordon on July 29, 2019
20/20 GeneSystems is expanding its marketing efforts and is on the verge of major revenue growth.